Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Artacent Amniotic Tissue for Treatment of Chronic Lower Extremity Diabetic Ulcers.
- Conditions
- Diabetic Foot Ulcer (DFU)Lower Extremity Chronic Ulcers in Diabetics
- First Posted Date
- 2025-10-21
- Last Posted Date
- 2025-10-21
- Lead Sponsor
- Tides Medical
- Target Recruit Count
- 30
- Registration Number
- NCT07219004
- Locations
- 🇺🇸
Three Rivers Wound and Hyperbaric Center, North Port, Florida, United States
🇺🇸Serena Group Reseach Center, Buffalo, New York, United States
🇺🇸Serena Group, Monroeville, Pennsylvania, United States
Rising Tide - Amniotic Tissue(s) Treatments for Chronic Diabetic Foot Ulcers
- Conditions
- Diabetic Foot Ulcer (DFU)Chronic Foot Ulcers
- First Posted Date
- 2024-11-08
- Last Posted Date
- 2025-02-10
- Lead Sponsor
- Tides Medical
- Target Recruit Count
- 240
- Registration Number
- NCT06681428
- Locations
- 🇺🇸
Limb Preservation Platform Inc, Fresno, California, United States
🇺🇸Angel City Research, Los Angeles, California, United States
🇺🇸Clemente Clinical Research, Los Angeles, California, United States
Efficacy and Safety of Artacent™ for Treatment Resistant Lower Extremity Venous and Diabetic Ulcers
- Conditions
- Foot Ulcer, DiabeticVenous Ulcer
- First Posted Date
- 2016-07-20
- Last Posted Date
- 2017-10-13
- Lead Sponsor
- Tides Medical
- Target Recruit Count
- 134
- Registration Number
- NCT02838784
- Locations
- 🇺🇸
Global Podiatry Partners, Inc, Arcadia, California, United States
🇺🇸Iberia Medical Center, New Iberia, Louisiana, United States
🇺🇸Ochsner Clinic Foundation, New Orleans, Louisiana, United States